945
Views
116
CrossRef citations to date
0
Altmetric
Research Article

The validation of the Italian Edinburgh Cognitive and Behavioural ALS Screen (ECAS)

, , , , , , , , , , , , , , & show all
Pages 489-498 | Received 07 Dec 2015, Accepted 28 Mar 2016, Published online: 24 May 2016

References

  • Phukan J, Pender NP, Hardiman O. Cognitive impairment in Amyotrophic Lateral Sclerosis. Lancet Neurol. 2007;6:994–1003.
  • Abrahams S. Executive dysfunction in ALS is not the whole story. J Neurol Neurosurg Psychiatry. 2013;84:474–5.
  • Goldstein LH, Abrahams S. Changes in cognition and behaviour in amyotrophic lateral sclerosis: nature of impairment and implications for assessment. Lancet Neurol. 2012;12:36–80.
  • Taylor LJ, Brown RG, Tsermentseli S, Al-Chalabi A, Shaw CE, Ellis CM, et al. Is language impairment more common than executive dysfunction in amyotrophic lateral sclerosis? J Neurol Neurosurg Psychiatry. 2012;84:494–8.
  • Abrahams S. Social Cognition in Amyotrophic Lateral Sclerosis. Neurodegener Dis Manag. 2012;1:397–405.
  • Cavallo M, Adenzato M, Macpherson SE, Karwig G, Enrici I, Abrahams S. Evidence of social understanding impairment in patients with amyotrophic lateral sclerosis. PLoS One. 2011;6:e25948.
  • Girardi A, Macpherson SE, Abrahams S. Deficits in emotional and social cognition in amyotrophic lateral sclerosis. Neuropsychology. 2011;25:53–65.
  • Phukan J, Elamin M, Bede P, Jordan N, Gallagher L, Byrne S, et al. The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population based study. J Neurol Neurosurg Psychiatry. 2012;83:102–8.
  • Woolley SC, York MK, Moore DH, Strutt AM, Murphy J, Schulz PE, Katz JS. Detecting frontotemporal dysfunction in ALS: utility of the ALS Cognitive Behavioral Screen (ALS-CBS). Amyotroph Lateral Scler. 2010;11:303–11.
  • Flaherty-Craig C, Brothers A, Dearman B, Eslinger P, Simmons Z. Penn State screen exam for the detection of frontal and temporal dysfunction syndromes: application to ALS. Amyotroph Lateral Scler. 2009;10:107–12.
  • Abrahams S, Newton J, Niven E, Foley J, Bak T. Screening for cognition and behaviour changes in ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:9–14.
  • Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011;134:2456–77.
  • Snowden JS, Rollinson S, Thompson JC, Harris JM, Stopford CL, Richardson AMT, et al. Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9orf72 mutations. Brain. 2012;135:693–708.
  • Niven E, Newton J, Foley J, Colville S, Swingler R, Chandran S, et al. Validation of the Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen (ECAS): a cognitive tool for motor disorders. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16:172–9.
  • Lulé D, Burkhardt C, Abdulla S, Böhm S, Kollewe K, Uttner I, et al. The Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen: a cross-sectional comparison of established screening tools in a German-Swiss population. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16:16–23.
  • Byrne S, Elamin M, Bede P, Shatunov A, Walsh C, Corr B, et al. Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population based cohort study. Lancet Neurol. 2012;11:232–40.
  • Boeve BF, Boylan KB, Graff-Radford NR, DeJesus-Hernandez M, Knopman DS, Pedraza O, et al. Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9orf72. Brain. 2012;135:765–83.
  • Brooks BR, Miller RG, Swash M, Munsat TL & World Federation of Neurology Research Group on Motor Neuron Disease. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders: Official publication of the World Federation of Neurology Research Group on Motor Neuron Disease. 2000;1:293–9.
  • Cedarbaum JS, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessment of respiratory function. J Neurol Sci. 1999;169:13–21.
  • DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxerl AL, Baker M, Rutherford NJ, et al. Expanded GGGGCC hexanucleotide repeat in non-coding region of C9orf72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72:245–56.
  • Nunnally JC, Bernstein IH. Psychometric theory (3rd edn). New York: McGraw-Hill, 1994.
  • Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB. A frontal assessment battery at bedside. Neurology. 2000;55:1621–6.
  • Pirani A, Nasreddine ZS, Tulipani C, Neri M. Montreal Cognitive Assessment (MOCA): uno strumento rapido per lo screening del Mild Cognitive Impairment. Dati preliminari della versione italiana. Atti IV Congresso Regionale Associazione Italiana Psicogeriatria, Bologna, 2007.
  • Alberici A, Geroldi C, Cotelli M. The Frontal Behavioural Inventory (Italian version) differentiates frontotemporal lobar degeneration variants from Alzheimer’s disease. Neurol Sci. 2007;28:80–6.
  • Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561–71.
  • Spielberger CD, Gorsuch RL, Lushene R. The State Trait Anxiety Inventory (STAI). Test Manual for Form X. Palo Alto: Consulting Psychologist Press, 2007 (trad. Italiana a cura di Lazzari R. E Pancheri P., “S.T.A.I. Questionario di autovalutazione dell’ansia di stato e di tratto”. Organizzazioni Speciali, Firenze, 1980).
  • Sheskin DJ. Handbook of parametric and non-parametric statistical procedures (4th edn). Boca Ranton: Chapman & Hall/CRC; 2007.
  • Osborne RA, Sekhon R, Johnston W, Kalra S. Screening for frontal lobe and general cognitive impairment in patients with amyotrophic lateral sclerosis. J Neurol Sci. 2014;336:191–6.
  • Strong MJ, Grace GM, Freedman M, Lomen-Hoerth C, Woolley S, Goldstein LH, et al. Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2009;10:131–46.
  • Donaghy C, Pinnock R, Abrahams S, Cardwell C, Hardiman O, Patterson V, et al. Slow saccades in bulbar-onset motor neuron disease. J Neurol. 2010;257:1134–40.
  • Cipresso P, Carelli L, Solca F, Meazzi D, Meriggi P, Poletti B, et al. The use of P300-based BCIs in amyotrophic lateral sclerosis: from augmentative and alternative communication to cognitive assessment. Brain and Behavior. 2012;2:479–98.
  • Keller J, Gorges M, Horn HT, Aho-Özhan HEA, Pinkhardt EH, Uttner I, et al. Eye-tracking controlled cognitive function tests in patients with amyotrophic lateral sclerosis: a controlled proof-of-principle study. J Neurol. 2015;262:1918–26.
  • Proudfoot M, Menke RAL, Sharma R, Berna CM, Hicks SL, Kennard C, et al. Eye-tracking in amyotrophic lateral sclerosis: a longitudinal study of saccadic and cognitive tasks. Amyotroph Lateral Scler Frontotemporal Degener 2015; Early Online: 1–11. doi:10.3109/21678421.2015.1054292.
  • Woolley SC, Zhang Y, Schuff N, Weiner MW, Katz JS. Neuroanatomical correlates of apathy in ALS using 4 Tesla diffusion tensor MRI. Amyotroph Lateral Scler. 2011;12:52–8.
  • Olney RK, Murphy J, Forshew D, Garwood E, Miller BL, Langmore S, et al. The effects of executive and behavioural dysfunction on the course of ALS. Neurology. 2005;65:1774–7.
  • Mioshi E, Lillo P, Kiernan M, Hodges J. Activities of daily living in motor neuron disease: role of behavioural and motor changes. J Clin Neurosci. 2012;19:552–6.
  • Chiò A, Vignola A, Mastro E, Giudici AD, Iazzolino B, Calvo A, et al. Neurobehavioural symptoms in ALS are negatively related to caregivers' burden and quality of life. Eur J Neurol. 2010;17:1298–303.
  • Ratti A, Corrado L, Castellotti B, Del Bo R, Fogh I, Cereda C, et al. C9orf72 repeat expansion in a large Italian ALS cohort: evidence of a founder effect. Neurobiol Aging. 2012;2528.e7–2528.e14.
  • Wicks P, Abrahams S, Masi D, Hejda-Forde S, Leigh PN, Goldstein LH. Prevalence of depression in a 12-month consecutive sample of patients with ALS. Eur J Neurol. 2007;14:993–1001.
  • Woolley SC, Moore DH, Katz JS. Insight in ALS: awareness of behavioural change in patients with and without FTD. Amyotroph Lateral Scler. 2010;11:52–6.
  • Flaherty-Craig CV, Brothers A, Yang C, Svoboda R, Simmons Z. Declines in problem solving and anosognosia in amyotrophic lateral sclerosis: application of Guilford's structure of intellect theory. Cogn Behav Neurol. 2011;24:26–34.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.